ELEVANCE HEALTH/ US0367521038 /
21.08.2024 15:39:49 | Diff. - | Volumen | Geld03:01:01 | Brief03:01:01 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
482,70EUR | - | 4 Umsatz: 1.954,40 |
-Geld Vol: - | -Brief Vol: - | 115,57 Mrd.EUR | - | - |
Aktiva
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sachanlagen | 1.801,5000 | 1.944,3000 | 2.019,8000 | 1.977,9000 | 2.174,9000 | ||||||
Immaterielle Vermögensgegenstände | 8.441 | 7.958,1000 | 8.158 | 7.964,9000 | 8.368,4000 | ||||||
Finanzanlagen | - | 2.231,8000 | 2.630,3000 | 2.796,3000 | 3.937,4000 | ||||||
Anlagevermögen | - | 29.836,1000 | 30.855,7000 | 30.768,2000 | 34.277,2000 | ||||||
Vorräte | - | - | - | - | - | ||||||
Forderungen | - | - | 11.943,6000 | 14.426,9000 | 14.978,2000 | ||||||
Liquide Mitteln | 1.582,1000 | 2.151,7000 | 2.113,5000 | 4.075,3000 | 3.608,9000 | ||||||
Umlaufvermögen | 29.745,8000 | 32.228,9000 | 30.862,1000 | 34.314,9000 | 36.262,8000 | ||||||
Aktiva, gesamt | 59.574,5000 | 62.065 | 61.717,8000 | 65.083,1000 | 70.540 |
Passiva
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Verbindlichkeiten aus Lieferungen und Leistungen | 3.426,3000 | - | 10.888,6000 | 11.907,5000 | 13.015,9000 | ||||||
Langfristige Schulden | - | 14.127,2000 | 15.324,5000 | 14.358,5000 | 17.382,2000 | ||||||
Verbindlichkeiten gegenüber Kreditinstituten | 400 | 400 | 540 | 440 | 1.275 | ||||||
Rückstellungen | 4.048,2000 | 3.897,3000 | 3.262,3000 | 3.446 | 2.373,8000 | ||||||
Verbindlichkeiten | 34.809,3000 | 37.813,7000 | 38.673,7000 | 39.982,7000 | 44.037,1000 | ||||||
Gezeichnetes Kapital | 2,9000 | - | 2,6000 | 2,6000 | 2,6000 | ||||||
Eigenkapital | 24.765,2000 | 24.251,3000 | 23.044,1000 | 25.100,4000 | 26.502,9000 | ||||||
Minderheitenanteile | 0.0000 | - | - | - | - | ||||||
Passiva, gesamt | 59.574,5000 | 62.065 | 61.717,8000 | 65.083,1000 | 70.540 |
Gewinn- und Verlustrechnung
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Umsatzerlöse | 71.023,5000 | 73.874,1000 | 79.156,5000 | 84.863 | 90.039,4000 | ||||||
Abschreibungen (Gesamt) | 245,3000 | 220,9000 | 230,1000 | 192,3000 | 168,4000 | ||||||
Betriebsergebnis | 4.442,9000 | 4.418,4000 | 4.753,1000 | 4.801,7000 | 4.175,4000 | ||||||
Zinsergebnis | -602,7000 | 600,7000 | -653 | -723 | -739 | ||||||
Ergebnis vor Steuern | 3.840,2000 | 4.368,1000 | 4.631 | 4.555,4000 | 3.963,8000 | ||||||
Ertragsteuern | 1.205,9000 | 1.808 | 2.071 | 2.085,6000 | 121 | ||||||
Gewinnanteil Minderheitsgesellschafter | 0.0000 | - | - | - | - | ||||||
Konzernjahresüberschuss | 2.489,7000 | 2.569,7000 | 2.560 | 2.469,8000 | 3.842,8000 |
Pro Aktie
Cash Flow
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow aus laufender Geschäftstätigkeit | 3.052,3000 | 3.369,3000 | 4.116 | 3.204,5000 | 4.184,8000 | ||||||
Cash Flow aus Investitionstätigkeit | -2.234,4000 | -974,9000 | -1.151,5000 | -513,9000 | -5.082,4000 | ||||||
Cash Flow aus Finanzierungstätigkeit | -1.717,8000 | -1.822,5000 | -2.997,4000 | -732,9000 | 426,9000 | ||||||
Veränderung der liquiden Mittel | -897,7000 | 564,8000 | -38,2000 | 1.961,8000 | -466,4000 | ||||||
Anzahl der Mitarbeiter | 48.200 | 51.500 | 53.000 | 53.000 | 56.000 |